↓ Skip to main content

Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders

Overview of attention for article published in Neuropsychopharmacology, September 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
5 X users

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
54 Mendeley
citeulike
1 CiteULike
Title
Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders
Published in
Neuropsychopharmacology, September 2016
DOI 10.1038/npp.2016.193
Pubmed ID
Authors

G Sanacora, H Heimer, D Hartman, S J Mathew, M Frye, C Nemeroff, R Robinson Beale

Abstract

Neuropsychopharmacology accepted article preview online, 19 September 2016. doi:10.1038/npp.2016.193.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 54 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 19%
Other 9 17%
Student > Bachelor 7 13%
Student > Master 5 9%
Student > Ph. D. Student 4 7%
Other 10 19%
Unknown 9 17%
Readers by discipline Count As %
Medicine and Dentistry 13 24%
Psychology 10 19%
Neuroscience 7 13%
Agricultural and Biological Sciences 2 4%
Biochemistry, Genetics and Molecular Biology 2 4%
Other 6 11%
Unknown 14 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 April 2022.
All research outputs
#1,404,622
of 24,072,790 outputs
Outputs from Neuropsychopharmacology
#613
of 4,276 outputs
Outputs of similar age
#25,823
of 325,148 outputs
Outputs of similar age from Neuropsychopharmacology
#19
of 68 outputs
Altmetric has tracked 24,072,790 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,276 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.5. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 325,148 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.